Gene · 8553
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. | Cancer Cell Int | 2023 | 38066642 | PubTator, text mining | PubMed |
| Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs. | BMC Bioinformatics | 2023 | 38066439 | PubTator, text mining | PubMed |
| Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer. | J Mammary Gland Biol Neoplasia | 2023 | 38066300 | PubTator, text mining | PubMed |
| Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials. | Sci Adv | 2023 | 38055824 | PubTator, text mining | PubMed |
| The roles of tissue-resident macrophages in sepsis-associated organ dysfunction. | Heliyon | 2023 | 38027963 | PubTator, text mining | PubMed |
| GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. | Genome Med | 2023 | 38008725 | PubTator, text mining | PubMed |
| Does decreased autophagy and dysregulation of LC3A in astrocytes play a role in major depressive disorder? | Transl Psychiatry | 2023 | 38001115 | PubTator, text mining | PubMed |
| Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53. | Cell Rep | 2023 | 37991919 | PubTator, text mining | PubMed |
| Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1. | J Biomed Res | 2023 | 37990879 | PubTator, text mining | PubMed |
| Circadian Rhythms in Cardiovascular Function: Implications for Cardiac Diseases and Therapeutic Opportunities. | Med Sci Monit | 2023 | 37986555 | PubTator, text mining | PubMed |
| Single-cell and spatial architecture of primary liver cancer. | Commun Biol | 2023 | 37985711 | PubTator, text mining | PubMed |
| Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species. | Nutrients | 2023 | 37960218 | PubTator, text mining | PubMed |
| Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with. | RMD Open | 2023 | 37949613 | PubTator, text mining | PubMed |
| Adjustment of p-value expression to ontology using machine learning for genetic prediction, prioritization, interaction, and its validation in glomerular disease. | Front Genet | 2023 | 37900183 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| A Small De Novo CNV Deletion of the Paternal Copy of FOXF1, Leaving lncRNA FENDRR Intact, Provides Insight into Their Bidirectional Promoter Region. | Noncoding RNA | 2023 | 37888207 | PubTator, text mining | PubMed |
| Effect of Hyperbaric Oxygen and Inflammation on Human Gingival Mesenchymal Stem/Progenitor Cells. | Cells | 2023 | 37887323 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| In silico engineering and simulation of RNA interferences nanoplatforms for osteoporosis treating and bone healing promoting. | Sci Rep | 2023 | 37875547 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies lactoferrin-induced quiescent circuits in neonatal macrophages. | Front Immunol | 2023 | 37868991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8553/papers?page=8